Position in ELAN
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$293,769
+$6,083 QoQ
Shares Held
11,937
-0.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#334
of 520 holders
Holding Since
Mar 2021
10 quarters on record
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Kestra Advisory Services, LLC holds $7,523,206 across 11 Drug Manufacturers - Specialty & Generic names. ELAN ranks #7 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
24,414 | $1,754,390 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
46,085 | $1,561,359 | |
| 3 | VTRS |
Viatris Inc
|
92,472 | $1,468,455 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
1,355 | $734,179 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
17,089 | $592,475 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
3,926 | $435,550 | |
| 7 | ELAN |
Elanco Animal Health Inc
This page
|
11,937 | $293,769 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
5,224 | $242,968 |
All Filings in ELAN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $293,769 | 11,937 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $287,686 | 12,022 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $167,778 | 7,414 | Shares | Sole | 2026-02-13 | |
| 2024-03-31 | $1,557,247 | 95,654 | Shares | Sole | 2024-05-15 | |
| 2022-06-30 | $241,174 | 12,286 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $290,094 | 11,119 | Shares | Sole | 2022-07-20 | |
| 2021-12-31 | $348,818 | 12,291 | Shares | Sole | 2022-07-25 | |
| 2021-09-30 | $390,716 | 12,252 | Shares | Sole | 2022-07-25 | |
| 2021-06-30 | $423,877 | 12,219 | Shares | Sole | 2022-07-26 | |
| 2021-03-31 | $335,111 | 11,379 | Shares | Sole | 2022-07-27 | |
| No filing history on record for this holder in this stock. | ||||||